Neurology®
The most widely read and highly cited peer-reviewed Neurology journal
Quick Search
Advanced Search
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Correspondence:
View responses
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mori, K.
Right arrow Articles by Sobue, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mori, K.
Right arrow Articles by Sobue, G.
Related Collections
Right arrow Guillain-Barre syndrome
Right arrow Chronic inflammatory demyelinating polyneuropathy
Neurology 2002;58:979-982
© 2002 American Academy of Neurology
Brief Communications

Chronic inflammatory demyelinating polyneuropathy presenting with features of GBS

K. Mori, MD, N. Hattori, MD, M. Sugiura, MD, H. Koike, MD, K. Misu, MD, M. Ichimura, MD, M. Hirayama, MD and G. Sobue, MD

From the Department of Neurology, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Address correspondence and reprint requests to Dr. Gen Sobue, Department of Neurology, Nagoya University Graduate School of Medicine, Nagoya 466-8550 Japan; e-mail: sobueg{at}med.nagoya-u.ac.jp

The authors report five patients with inflammatory demyelinating polyneuropathy with a Guillain–Barré syndrome (GBS)–like onset and initial clinical features, but with persistent symptoms similar to chronic inflammatory demyelinating polyneuropathy (CIDP). Patients in the chronic phase improved with corticosteroid or IV immunoglobulin therapy. Patients with apparent GBS who show persistent symptoms may benefit from corticosteroids or other treatment that is beneficial in the management of CIDP.




This article has been cited by other articles:


Home page
 NeurologyHome page
L. Ruts, R. van Koningsveld, and P. A. van Doorn
Distinguishing acute-onset CIDP from Guillain-Barre syndrome with treatment related fluctuations
Neurology, July 12, 2005; 65(1): 138 - 140.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
I. Korn-Lubetzki, I. Steiner, K. Mori, N. Hattori, M. Yamamoto, and G. Sobue
Chronic inflammatory demyelinating polyneuropathy presenting with features of GBS
Neurology, December 10, 2002; 59(11): 1823 - 1824.
[Full Text] [PDF]

Correspondence:

Read all Correspondence

Chronic inflammatory demyelinating polyneuropathy presenting with features of GBS
Isabelle Korn-Lubetzki, et al.
Neurology Online, 16 Aug 2002 [Full text]
Reply to Letter to the Editor
Gen Sobue, et al.
Neurology Online, 16 Aug 2002 [Full text]